Where can I buy Capmatinib more reliably?

Introduction: Capmatinib is a drug used to treat metastatic non-small cell lung cancer. It has not yet been approved for marketing in mainland China. Therefore, it may be difficult to purchase capmatinib in mainland China. If you need to purchase capmatinib in mainland China, you can purchase it through the following methods. In addition, if you are in other countries or regions, you can consult your local doctor or pharmacy to learn about local purchasing channels and regulations.

Where to buy Capmatinib more reliably

1. Hospital pharmacy: Some large general hospitals or cancer hospitals in your country or region may have Capmatinib in pharmacies, and patients can buy it at the hospital with a doctor's prescription.

2. Officially authorized online pharmacies: Choose an online pharmacy with formal qualifications and good reputation to purchase capmatinib.

3. Overseas purchase: If you have overseas relatives and friends, you can ask them to help buy capmatinib and mail it to the country.

4. Professional overseas medical service institutions: Choose medical service institutions that cooperate with pharmacies at home and abroad. They can help patients obtain drugs, provide guarantee contracts, and can buy multiple versions of capmatinib.

5. Patient associations or charitable organizations: Some organizations may provide drug assistance or funding programs to help patients obtain capmatinib at a lower price or for free.

6. Hainan Boao Lecheng International Medical Tourism Pilot Zone: Capmatinib has been approved for use in specific medical institutions in this area. Patients can consider going to this area to purchase capmatinib.

When purchasing capmatinib, be sure to ensure the formality of the channels to avoid purchasing fake and shoddy products. At the same time, you should consult a doctor or medical professional before purchasing to ensure the safety of the medication.

Special population use of capmatinib

1. Pregnancy: According to the findings of animal studies and its mechanism of action, capmatinib can cause fetal harm when administered to pregnant women. There is currently no available data on the use of capmatinib in pregnant women. Pregnant women are advised to pay attention to the potential risks to the fetus.

2. Medication in children: The safety and effectiveness of capmatinib in pediatric patients have not yet been determined.

3. Medication for the elderly: In GEOMETRY mono-1, 57% of the 334 patients were 65 years or older, and 16% were 75 years or older. No overall differences in safety or effectiveness were observed between these patients and younger patients.